Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies

Published: June 2013
No. of Pages: 123
    ReportsandReports

This report is available at 15% Discount till 31st Jan 2017. To avail discount please contact at +1-888-391-5441 / sales@reportsandreports.com.


There are more than 1400 sustained or controlled release drugs approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of the overall international pharmaceutical market. Utilization of generic in terms of volume is higher in the US and lower in Japan, 89% and 24% respectively.

The oral drug delivery market remains the largest slice of the overall drug delivery market, with more than 52% of market share. It is presently valued at $49 billion and is expected to reach over $90 billion by 2016, at a CAGR of 11%. The growth in the oral drug delivery market shall be driven primarily by newer technologies enabling controlled release formulations of oral drugs and oral formulations of injectable only drugs. Global injectable drug delivery market is expected to be worth $29b by 2015.

Novel drug delivery systems (NDDS) offer many more advantages, which include improved therapy by increasing the efficacy and duration of drug activity, increased patient compliance through decreased dosing frequency and convenient routes of administration, and improved targeting for a specific site to reduce unwanted side effects. The challenge for both drug and drug delivery companies is to deliver both existing and emerging drug technologies in a manner that improves the current benefits enjoyed by the patients.

The generic market with reference to innovative molecule (NCE) has become very competitive as several companies have already filed ANDA's for potential generic drugs in the near term. The study of the novel drug delivery companies and their formulation technologies will provide the potential value added opportunity in the generic field in terms of patient’s compliance or bioavailability enhancement. It will also provide an enhanced life cycle for drugs under patent coverage (life cycle extension).

This comprehensive report on novel drug delivery system focuses mainly on the oral and injectable formulations of pharmaceuticals and specialty companies. This report enumerates the various formulation technologies involved in making value added formulations, pharmaceutical applications and advantages of specific technologies. Wherever possible, marketed drugs using a similar technology have been discussed as proof of validation along with the status of additional pipeline. The discussed proprietary formulation technologies includes Colal, Glide SDI, Arestat, GeoClock, GeoMatrix, FlashTab, Lock Tab, Medusa, Eligen, Oradur, EnteriCare and Saber.

This report will be helpful for those pharma companies who are exploring novel opportunities for their growth by in-licensing formulation technology or value added pipeline drugs available/being studied in the market.

Published By: MP Advisors
Product Code: MP Advisors9


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • United States SSRI Market Report 2016

    Notes: Sales, means the sales volume of SSRI Revenue, means the sales value of SSRI This report studies sales (consumption) of SSRI in United States market, focuses on the top players, with sales, price, revenue and market share for each player,...

  • Global SSRI Sales Market Report 2016

    Notes: Sales, means the sales volume of SSRI Revenue, means the sales value of SSRI This report studies sales (consumption) of SSRI in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/coun...

  • United States Eyedrops Market Report 2016

    Notes: Sales, means the sales volume of Eyedrops Revenue, means the sales value of Eyedrops This report studies sales (consumption) of Eyedrops in United States market, focuses on the top players, with sales, price, revenue and market share for ...

  • Japan Eyedrops Market Report 2016

    Notes: Sales, means the sales volume of Eyedrops Revenue, means the sales value of Eyedrops This report studies sales (consumption) of Eyedrops in Japan market, focuses on the top players, with sales, price, revenue and market share for each pla...

  • Europe Eyedrops Market Report 2016

    Notes: Sales, means the sales volume of Eyedrops Revenue, means the sales value of Eyedrops This report studies sales (consumption) of Eyedrops in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top...

  • China Eyedrops Market Research Report 2016

    Notes: Sales, means the sales volume of Eyedrops Revenue, means the sales value of Eyedrops This report studies Eyedrops in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for ...

  • Global Eyedrops Sales Market Report 2016

    Notes: Sales, means the sales volume of Eyedrops Revenue, means the sales value of Eyedrops This report studies sales (consumption) of Eyedrops in Global market, especially in United States, China, Europe, Japan, focuses on top players in these ...

  • Europe Myeloproliferative Disorders Clinical Trials Market Report 2016

    Notes: Sales, means the sales volume of Myeloproliferative Disorders Clinical Trials Revenue, means the sales value of Myeloproliferative Disorders Clinical Trials This report studies sales (consumption) of Myeloproliferative Disorders Clinical ...

  • United States Tramadol Market Report 2016

    Notes: Sales, means the sales volume of Tramadol Revenue, means the sales value of Tramadol This report studies sales (consumption) of Tramadol in United States market, focuses on the top players, with sales, price, revenue and market share for ...

  • United States Meloxicam Market Report 2016

    Notes: Sales, means the sales volume of Meloxicam Revenue, means the sales value of Meloxicam This report studies sales (consumption) of Meloxicam in United States market, focuses on the top players, with sales, price, revenue and market share f...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: